Acute Severe Colitis

Learning Objectives:

To characterize the natural history of acute severe colitis in patients with inflammatory bowel disease.
To assess the clinical management of patients with IBD who are hospitalized in a day-by-day fashion.
To appraise the role of “salvage therapies” such as infliximab and Janus kinase inhibitors in patients with steroid-refractory acute severe colitis.
To determine the important role of early surgical consultation in patients who are hospitalized with acute severe colitis.

Speaker:

Edward V. Loftus, Jr., M.D., F.A.C.G., A.G.A.F.

Maxine and Jack Zarrow Family Professor of Gastroenterology Specifically in IBD
Mayo Clinic College of Medicine and Science
Co-Director, Advanced Inflammatory Bowel Disease Fellowship
Mayo Graduate School of Medicine
Consultant, Division of Gastroenterology and Hepatology
Mayo Clinic
Rochester, Minnesota, USA

Edward V. Loftus, Jr. is a gastroenterologist with extensive experience as a lecturer and clinician researcher in the field of inflammatory bowel diseases. He is the Maxine and Jack Zarrow Family Professor of Gastroenterology Specifically for IBD at Mayo Clinic College of Medicine and Science in Rochester, Minnesota, USA. Professor Loftus has published over 525 original articles, book chapters, or editorials and more than 800 abstracts. He was awarded AGA’s Distinguished Clinician Award and the IMIBD section’s Research Mentor Award in 2019. Professor Loftus has been the principal investigator on several funded studies focusing on the epidemiology and natural history of inflammatory bowel disease and has served as the local PI on multiple clinical trials of investigational agents for IBD. He serves on the steering committees of several clinical development programs in IBD.

Back to Main Website Close X